@nationalsecuritylaw.org
Public interest 501(c)(3) law firm for natsec & info/privacy law. Website https://www.nationalsecuritylaw.org. Charitable tax-exempt donations always welcome; details on website front page. Media email Media@ NationalSecurityLaw.org, others email Kel there
@jmaraganore.bsky.social
Founding CEO of Alnylam Pharmaceuticals. RNAi therapeutics pioneer. CEO and Principal of JMM Innovations, LLC. Committed to advancing biomedical innovation to patients.
@erictopol.bsky.social
physician-scientist, author, editor https://www.scripps.edu/faculty/topol/ Ground Truths https://erictopol.substack.com SUPER AGERS https://www.simonandschuster.com/books/Super-Agers/Eric-Topol/9781668067666
@daphnezohar.bsky.social
Founder & CEO of www.SeaportTx.com developing new medicines for neuropsychiatric disorders. Co-founder Karuna Tx (KarXt/Cobenfy now at BMS). Founding CEO & Senior Advisor www.puretechhealth.com. Co founder/host @BiotechCH. Board of BIO #Biotech #BioSky
@pdrworld.bsky.social
Biotech exec, pro drug developer. Amateur everything else: COOKING, ferments, preserving, charcuterie, fishing, gardening, weightlifting, BIRDER, photography, physics, literature, writer, history, DAD
@drrichjlaw.bsky.social
Chief Business Officer of Haya Therapeutics! (formerly Exscientia/Recursion CBO), computational chemist by training (Oxford, UCSD, LLNL & Evotec), bike racer, ex-Oxford rower & LFC fan! #YNWA.
@afbiotech.bsky.social
@gilman.bsky.social
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant, #BioSky. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/
@bijans.bsky.social
Healthcare investor. Howard Stern. Arcade Fire. Bowie. U2. California dreamin'
@scottgottliebmd.bsky.social
Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Public boards: Pfizer, Illumina, TempusAI.
@antonioregalado.bsky.social
Journalist covering biotechnology for MIT Technology Review. Scoops about new methods in genetics and cell biology. The "playing God" beat. Gene editing, gene therapy, ancient DNA, synthetic embryos, cloning, etc.
@dshaywitz.bsky.social
Rangy MD/PhD executive applying AI & digital technologies to biopharma & healthy aging. Player-coach. #Biosky #Medsky Also Timmerman Report, DBMI@HMS, AEI; https://www.astoundinghealthtech.com/
@biotechtv.bsky.social
News, stories, and educational videos about the biotechnology sector. Bringing biotech to life. 📺
@dbsable.bsky.social
Doctor/teacher/writer. Ob/gyn and IVF doc. Roadie for Priya Mayadas. Adjunct @Columbia https://dbsable.substack.com
@mppai.bsky.social
Biotech investor relations. Voracious reader, eater & wine drinker. Personal account; posts & opinions are my own. she/her
@dereklowe.bsky.social
Medicinal chemist / chemical biologist, author of “In the Pipeline” at http://science.org/blogs/pipeline. [email protected] and on Signal at Dblowe.18 All opinions are mine; I don’t speak for my employer in any way.
@matthewherper.bsky.social
I write about medicine at STAT. This is biology's century. Every data point has a face.
@maverickny.bsky.social
Scientist, cancer geek, journalist, Londoner, always curious, adventurer, explorer, immigrant, lover of curry, fine wine & football
@pearlf.bsky.social
From Boston, MA. I'm @pearlf on the other blue-colored place. Founder of Cambridge BioPartners, Inc. I post mostly healthcare-related and biotech-related news items.
@sarahkarlin-smith.bsky.social
Journalist covering intersection of pharma, health policy & politics for the Pink Sheet. On Signal at SarahKarlinSmith.34 KFF Health News’ ‘What The Health?’ panelist. Co-created Prescription PULSE at Politico. GWU alum, dabbled in SMPA adjunct-ness.
@investrclouseau.bsky.social
Not a CFA, biotech investor, still recovering from a decade in neuroscience, so now focusing on drugs that work
@applehelix.bsky.social
Entrepreneur. Drug hunter. Novice biotech scripophile. Anti-ideologues. Proudly blocked by Vinay Prasad. http://linkedin.com/in/jliang1/
@lisamjarvis.bsky.social
Chicago-based health & science columnist for Bloomberg Opinion @opinion.bsky.social. Writing about public health, medicine, emerging technologies (Crispr!), biotech & pharma. opinions=mine, She/her. Signal: lisajarvis.77
@adamfeuerstein.bsky.social
Reporter at STAT. The Harry Kane of biotech. Dog ❤️er. Polk Award winner. Said one analyst: The likes of Adam Feuerstein attack viciously.
@carlquintanilla.bsky.social
25+ years at @CNBC and @NBCNews / @WSJ alum / board member, NY City Center
@franksdavid.bsky.social
Biotech R&D strategy @ Pharmagellan. Prof of Practice of Biotech @ Tufts Biology. Bio, books, blog & more at www.pharmagellan.com. #biosky
@michaelwong.bsky.social
Biotech venture creation and pharma partnerships at Flagship Pioneering. Company builder by practice, placental biologist by training. 🇨🇦
@carolynbertozzi.bskyverified.social
Baker Family Director, Sarafan ChEM-H, Stanford University and HHMI; EIC of ACS Cent Sci; All views and opinions expressed are my own.
@jacobplieth.bsky.social
Journalist @ ApexOnco. The Wolverine Of Biotech / Mr ASH. Once had a blue tick. Interested in: oncology. Not interested in: what stock you bought today.
@biotechmiller.bsky.social
20+ years in the biotech business. Analyst, portfolio manager, VC, & now doing communications and strategy at Curevo Vaccine. Avid sailor who races. All views are my own. What are you doing with your one wild and precious life? (Mary Oliver)
@profgalloway.com
Professor of Marketing at NYU Stern School of Business, serial entrepreneur, and host of the Prof G and Pivot Podcasts.
@ivanthek.bsky.social
Lead Independent Director of Finance Bluesky. Portfolio Mangler. Take each post with a grain of sea salt. Not opinions of Bridgewater LLC.
@footnoted.bsky.social
Reading SEC filings intensively and obsessively for 20 years. After spending the past year in Paris, I’m back in LA. Home of the Friday Night 💩. Learn more at footnoted.com. Signal: footnoted.90
@andrewrsorkin.bsky.social
@NYTimes Columnist/Editor & @SquawkCNBC Co-Anchor. Author, Too Big To Fail. Founder, @DealBook. Co-Creator, BILLIONS @Showtime.
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: [email protected]